Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

European Innovation Council · Running

REGENERAR Improving the Effectiveness and Safety of Epigenetic Editing in Brain Regeneration

Coordinator
Universidade De Coimbra, Portugal
Runs
1 March 2024 to 29 February 2028
Status
Running
EU funding
€2.9m
Total cost
€2.9m
Partners
6 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101129812

What the project is doing

In the project's own words, from its summary on CORDIS.

The central nervous system has a limited capacity for self-repair. Therefore, technologies to replace lost neurons after an injury, including stroke or neurodegenerative diseases, are of great need. The project REGENERAR aims to develop a non-viral delivery formulation up to TRL4 for the delivery of an epigenetic reprogramming formulation to reprogram glial cells into neurons. The in vitro safety and targeting of the formulation will be tested against glial cells and organotypic cortical slice cultures.

Several routes of administrations will be tested to enhance the accumulation of the formulation in the brain. In addition, the in vivo safety, elimination, targeting and epigenetic reprogramming will be evaluated. In addition, toxicological studies will be performed in GLP conditions to evaluate both in vivo systemic and local (brain) effects of the formulation. The development of the non-viral formulation will take in account the contributes of key stakeholders in the area of gene editing, health institutions, patient associations, among others.

A roadmap will be developed for upscaling innovation to higher TRL´s upon the end of the action.

Topics

Who is involved

OrganisationCityCountryRole
Universidade De CoimbraCoimbraPortugalCoordinator
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbHNeuherbergGermanyParticipant
Hovione Farmaciencia SALouresPortugalParticipant
Sociedade Portuguesa De Inovacao Consultadoria Empresarial E Fomento Da Inovacao SAPortoPortugalParticipant
Single Technologies ABStockholmSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI